| In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin S Piplani, PK Singh, DA Winkler, N Petrovsky Scientific reports 11 (1), 13063, 2021 | 101 | 2021 |
| Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection L Li, Y Honda-Okubo, Y Huang, H Jang, MA Carlock, J Baldwin, S Piplani, ... Vaccine 39 (40), 5940-5953, 2021 | 53 | 2021 |
| In silico comparison of spike protein-ACE2 binding affinities across species; significance for the possible origin of the SARS-CoV-2 virus S Piplani, PK Singh, DA Winkler, N Petrovsky arXiv preprint arXiv:2005.06199, 2020 | 48 | 2020 |
| Artificial intelligence in vaccine and drug design S Thomas, A Abraham, J Baldwin, S Piplani, N Petrovsky Vaccine Design: Methods and Protocols, Volume 1. Vaccines for Human Diseases …, 2022 | 34 | 2022 |
| TLR2 agonistic small molecules: detailed structure–activity relationship, applications, and future prospects A Kaur, D Kaushik, S Piplani, SK Mehta, N Petrovsky, DB Salunke Journal of Medicinal Chemistry 64 (1), 233-278, 2020 | 29 | 2020 |
| BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant D Kaushik, S Dhingra, MT Patil, S Piplani, V Khanna, Y Honda-Okubo, ... Human Vaccines & Immunotherapeutics 16 (8), 1989-1996, 2020 | 20 | 2020 |
| Neuroinformatics analyses reveal GABAt and SSADH as major proteins involved in anticonvulsant activity of valproic acid S Piplani, PK Verma, A Kumar Biomedicine & Pharmacotherapy 81, 402-410, 2016 | 20 | 2016 |
| Homology modelling and molecular docking studies of human placental cadherin protein for its role in teratogenic effects of anti-epileptic drugs S Piplani, V Saini, RRK Niraj, A Pushp, A Kumar Computational Biology and Chemistry 60, 1-8, 2016 | 18 | 2016 |
| Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective J Baldwin, S Piplani, IG Sakala, Y Honda-Okubo, L Li, N Petrovsky Bioanalysis 13 (24), 1805-1826, 2021 | 15 | 2021 |
| Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies S Piplani, PK Singh, DA Winkler, N Petrovsky Molecular biomedicine 2 (1), 28, 2021 | 10 | 2021 |
| Potential COVID-19 Therapies from computational repurposing of drugs and natural products against the SARS-CoV-2 helicase S Piplani, P Singh, DA Winkler, N Petrovsky International Journal of Molecular Sciences 23 (14), 7704, 2022 | 6 | 2022 |
| Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (Mpro) as Potential COVID-19 Therapies S Piplani, P Singh, N Petrovsky, DA Winkler Frontiers in Molecular Biosciences 9, 781039, 2022 | 6 | 2022 |
| Stereoisomeric Pam 2 CS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvants A Kaur, S Piplani, D Kaushik, J Fung, IG Sakala, Y Honda-Okubo, ... RSC Medicinal Chemistry 13 (5), 622-637, 2022 | 6 | 2022 |
| Deep Meta Tool: GUI Tool to Obtain Mean and Standard Deviation (SD) from Median and Interquartile Range (IQR) D Sharma, SP Ulaganathan, V Sharma, S Piplani, RRK Niraj | 6 | 2021 |
| Computational screening of repurposed drugs and natural products against SARS-Cov-2 main protease (Mpro) as potential COVID-19 therapies S Piplani, P Singh, N Petrovsky, DA Winkler arXiv preprint arXiv:2009.00744, 2020 | 5 | 2020 |
| Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics S Piplani, P Singh, N Petrovsky, DA Winkler International Journal of Molecular Sciences 24 (4), 4192, 2023 | 4 | 2023 |
| Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent D Kaushik, JT Granato, GC Macedo, PRB Dib, S Piplani, J Fung, ... Journal of Pharmacy and Pharmacology 73 (9), 1180-1190, 2021 | 4 | 2021 |
| Structure− Activity Relationships Towards the Identification of High-Potency Selective Human Toll-Like Receptor-7 Agonist D Kaushik, A Kaur, M Patil, B Sihag, S Piplani, I Sakala, Y Honda-Okubo, ... | 2 | 2024 |
| Molecular dynamics of rab7:: REP1:: GGTase-II ternary complex and identification of their putative drug binding sites M Sindhu, V Saini, S Piplani, A Kumar Indian Journal of Pharmaceutical Sciences 75 (1), 23, 2013 | 2 | 2013 |
| Predicting Diagnostic Potential of Cathepsin in Epithelial Ovarian Cancer: A Design Validated by Computational, Biophysical and Electrochemical Data H Ranade, P Paliwal, AA Chaudhary, S Piplani, HA Rudayni, ... Biomolecules 12 (1), 53, 2021 | 1 | 2021 |
